Trial intelligence / Profile preview

Parasternal blocks for analgesia after cardiac surgery

NCT05191745Phase 3Completed

Sponsor
Jewish General Hospital
Start
Jan 2022
Primary completion
Apr 2023
Modality
Recombinant Proteins and Enzymes, Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of bupivacaine, epinephrine, dexamethasone, dexmedetomidine in postoperative pain, sponsored by Jewish General Hospital. Started Jan 2022; status: completed.

02

Drugs

bupivacaineepinephrinedexamethasonedexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05191745.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05191745.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call